MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization

Authors :: Bielack, S.S.
Smeland, S.
Whelan, J.
Marina, N.
Hook, J.
Jovic, G.
Krailo, M.D.
Butterfass-Bahloul, T.
Kuhne, T.
Eriksson, M.
Teot, L.A.
Gelderblom, H.
Kager, L.
Hall, K.S.
Gorlick, R.G.
Randall, R.L.
Hogendoorn, P.C.W.
Calaminus, G.
Sydes, M.R.
Bernstein, M.L.
Source :: Journal of Clinical Oncology, 31(15)
Publication Year :: 2013

Tools